Goodricke [GOODRICKE] vs Venky's (India [VENKEYS] Detailed Stock Comparison
Goodricke
BSE
Loading...
Venky's (India
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Goodricke wins in 6 metrics, Venky's (India wins in 11 metrics, with 0 ties. Venky's (India appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Goodricke | Venky's (India | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 21.81 | 18.28 | Venky's (India |
| Price-to-Book Ratio | 1.62 | 1.44 | Venky's (India |
| Debt-to-Equity Ratio | 18.75 | 11.50 | Venky's (India |
| PEG Ratio | N/A | 27.97 | N/A |
| EV/EBITDA | 46.86 | 11.56 | Venky's (India |
| Profit Margin (TTM) | 1.19% | 3.53% | Venky's (India |
| Operating Margin (TTM) | -3.08% | 1.83% | Venky's (India |
| EBITDA Margin (TTM) | N/A | 1.83% | N/A |
| Return on Equity | 7.41% | 8.20% | Venky's (India |
| Return on Assets (TTM) | 3.13% | 4.05% | Venky's (India |
| Free Cash Flow (TTM) | $290.20M | $205.00M | Goodricke |
| Dividend Yield | N/A | 0.43% | N/A |
| 1-Year Return | -7.53% | -34.20% | Goodricke |
| Price-to-Sales Ratio (TTM) | 0.48 | 0.64 | Goodricke |
| Enterprise Value | $4.75B | $19.84B | Venky's (India |
| EV/Revenue Ratio | 0.52 | 0.60 | Goodricke |
| Gross Profit Margin (TTM) | 41.80% | 23.59% | Goodricke |
| Revenue per Share (TTM) | $420 | $2,347 | Venky's (India |
| Earnings per Share (Diluted) | $9.30 | $82.78 | Venky's (India |
| Beta (Stock Volatility) | -0.19 | 0.47 | Goodricke |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Goodricke vs Venky's (India Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Goodricke | 1.98% | -14.78% | -10.75% | 11.00% | -9.29% | -30.05% |
| Venky's (India | -1.19% | -3.80% | -9.48% | -12.17% | -13.59% | -21.86% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Goodricke | -7.53% | -8.66% | -33.37% | 38.20% | 57.05% | 149.69% |
| Venky's (India | -34.20% | -29.92% | 8.44% | 315.60% | 196.65% | 942.84% |
Performance & Financial Health Analysis: Goodricke vs Venky's (India
| Metric | GOODRICKE | VENKEYS |
|---|---|---|
| Market Information | ||
| Market Cap | ₹4.38B | ₹21.32B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 10,844 | 28,405 |
| 90 Day Avg. Volume | 8,747 | 22,175 |
| Last Close | ₹200.75 | ₹1,424.80 |
| 52 Week Range | ₹162.00 - ₹357.40 | ₹1,422.00 - ₹2,559.95 |
| % from 52W High | -43.83% | -44.34% |
| All-Time High | ₹545.00 (Nov 27, 2017) | ₹4,725.00 (Apr 09, 2018) |
| % from All-Time High | -63.17% | -69.85% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.12% | -0.06% |
| Quarterly Earnings Growth | -0.75% | -0.60% |
| Financial Health | ||
| Profit Margin (TTM) | 0.01% | 0.04% |
| Operating Margin (TTM) | -0.03% | 0.02% |
| Return on Equity (TTM) | 0.07% | 0.08% |
| Debt to Equity (MRQ) | 18.75 | 11.50 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹125.25 | ₹1,047.33 |
| Cash per Share (MRQ) | ₹2.66 | ₹220.19 |
| Operating Cash Flow (TTM) | ₹-23,000,000 | ₹663.30M |
| Levered Free Cash Flow (TTM) | ₹200.60M | ₹99.58M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.43% |
| Last 12-Month Dividend | ₹0.00 | ₹7.00 |
Valuation & Enterprise Metrics Analysis: Goodricke vs Venky's (India
| Metric | GOODRICKE | VENKEYS |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 21.81 | 18.28 |
| Forward P/E | N/A | 27.97 |
| PEG Ratio | N/A | 27.97 |
| Price to Sales (TTM) | 0.48 | 0.64 |
| Price to Book (MRQ) | 1.62 | 1.44 |
| Market Capitalization | ||
| Market Capitalization | ₹4.38B | ₹21.32B |
| Enterprise Value | ₹4.75B | ₹19.84B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.52 | 0.60 |
| Enterprise to EBITDA | 46.86 | 11.56 |
| Risk & Other Metrics | ||
| Beta | -0.19 | 0.47 |
| Book Value per Share (MRQ) | ₹125.25 | ₹1,047.33 |
Financial Statements Comparison: Goodricke vs Venky's (India
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | GOODRICKE | VENKEYS |
|---|---|---|
| Revenue/Sales | ₹1.32B | ₹8.43B |
| Cost of Goods Sold | ₹767.30M | ₹6.44B |
| Gross Profit | ₹551.10M | ₹1.99B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹-557.40M | ₹153.90M |
| EBITDA | ₹-405.60M | ₹372.50M |
| Pre-Tax Income | ₹-402.30M | ₹229.90M |
| Income Tax | ₹-36.60M | ₹96.90M |
| Net Income (Profit) | ₹-365.70M | ₹133.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | GOODRICKE | VENKEYS |
|---|---|---|
| Cash & Equivalents | ₹49.70M | ₹167.50M |
| Total Current Assets | ₹2.99B | ₹13.43B |
| Total Current Liabilities | ₹2.51B | ₹5.31B |
| Long-Term Debt | ₹203.50M | ₹31.30M |
| Total Shareholders Equity | ₹2.71B | ₹14.76B |
| Retained Earnings | N/A | N/A |
| Property, Plant & Equipment | ₹2.87B | ₹6.35B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | GOODRICKE | VENKEYS |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | GOODRICKE | VENKEYS |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 10,844 | 28,405 |
| Average Daily Volume (90 Day) | 8,747 | 22,175 |
| Shares Outstanding | 21.60M | 14.09M |
| Float Shares | 5.17M | 4.88M |
| % Held by Insiders | 0.76% | 0.61% |
| % Held by Institutions | 0.00% | 0.01% |
Dividend Analysis & Yield Comparison: Goodricke vs Venky's (India
| Metric | GOODRICKE | VENKEYS |
|---|---|---|
| Last 12-Month Dividend | ₹0.00 | ₹7.00 |
| Last 12-Month Dividend Yield | N/A | 0.43% |
| 3-Year Avg Annual Dividend | ₹1.00 | ₹8.67 |
| 3-Year Avg Dividend Yield | 1.24% | 0.40% |
| 3-Year Total Dividends | ₹3.00 | ₹26.00 |
| Ex-Dividend Date | Jul 19, 2022 | Aug 23, 2024 |